Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP237940.RAV06lcjT0qVmqbcsEB2sjaSnSYsJcFoGKsHeF-A_W8mU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP237940.RAV06lcjT0qVmqbcsEB2sjaSnSYsJcFoGKsHeF-A_W8mU130_assertion type Assertion NP237940.RAV06lcjT0qVmqbcsEB2sjaSnSYsJcFoGKsHeF-A_W8mU130_head.
- NP237940.RAV06lcjT0qVmqbcsEB2sjaSnSYsJcFoGKsHeF-A_W8mU130_assertion description "[Tumor tissues from 71 patients with CRC were assayed to determine the antigen levels of urokinase-type plasminogen activator (uPA), uPA receptor (uPAR), and plasminogen activator inhibitor-1 and -2 (PAI-1 and PAI-2), as well as immunohistochemical expression of VEGF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP237940.RAV06lcjT0qVmqbcsEB2sjaSnSYsJcFoGKsHeF-A_W8mU130_provenance.
- NP237940.RAV06lcjT0qVmqbcsEB2sjaSnSYsJcFoGKsHeF-A_W8mU130_assertion evidence source_evidence_literature NP237940.RAV06lcjT0qVmqbcsEB2sjaSnSYsJcFoGKsHeF-A_W8mU130_provenance.
- NP237940.RAV06lcjT0qVmqbcsEB2sjaSnSYsJcFoGKsHeF-A_W8mU130_assertion SIO_000772 12405290 NP237940.RAV06lcjT0qVmqbcsEB2sjaSnSYsJcFoGKsHeF-A_W8mU130_provenance.
- NP237940.RAV06lcjT0qVmqbcsEB2sjaSnSYsJcFoGKsHeF-A_W8mU130_assertion wasDerivedFrom befree-20140225 NP237940.RAV06lcjT0qVmqbcsEB2sjaSnSYsJcFoGKsHeF-A_W8mU130_provenance.
- NP237940.RAV06lcjT0qVmqbcsEB2sjaSnSYsJcFoGKsHeF-A_W8mU130_assertion wasGeneratedBy ECO_0000203 NP237940.RAV06lcjT0qVmqbcsEB2sjaSnSYsJcFoGKsHeF-A_W8mU130_provenance.